t
| Date | 29 Apr 2025 |
| Time | 15:09:31 |
| Category | Holding(s) in company |
| ID | 6771G |
|
FORM 8.3 |
|||||||
|
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY |
|||||||
|
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR |
|||||||
|
MORE |
|||||||
|
Rule 8.3 of the Takeover Code (the "Code") |
|||||||
|
1. |
KEY INFORMATION |
||||||
|
(a) |
Full name of discloser: |
|
Barclays PLC. |
||||
|
(b) |
Owner or controller of interest and short |
|
|||||
|
|
positions disclosed, if different from 1(a): |
||||||
|
(c) |
Name of offeror/offeree in relation to whose |
ALLIANCE PHARMA PLC |
|||||
|
|
relevant securities this form relates: |
||||||
|
(d) |
If an exempt fund manager connected with an |
|
|||||
|
|
offeror/offeree, state this and specify identity of |
||||||
|
|
offeror/offeree: |
||||||
|
(e) |
Date position held/dealing undertaken: |
28 Apr 2025 |
|||||
|
(f) |
In addition to the company in 1(c) above, is the discloser making |
NO |
|
|
|||
|
|
disclosures in respect of any other party to the offer? |
|
|
||||
|
2. |
POSITIONS OF THE PERSON MAKING THE DISCLOSURE |
||||||
|
(a) |
Interests and short positions in the relevant securities of the offeror or offeree |
|
|||||
|
|
to which the disclosure relates following the dealing(if any) |
|
|||||
|
Class of relevant security: |
1p ordinary |
||||||
|
|
Interests |
Short Positions |
|||||
|
|
Number |
(%) |
Number |
(%) |
|||
|
(1) |
Relevant securities owned |
|
|
|
|
||
|
|
and/or controlled: |
|
|
6,007,942 |
1.11% |
1,776,308 |
0.33% |
|
(2) |
Cash-settled derivatives: |
|
|
|
|
||
|
|
and/or controlled: |
|
|
1,005,621 |
0.19% |
6,007,942 |
1.11% |
|
(3) |
Stock-settled derivatives (including options) |
|
|
|
|
||
|
|
and agreements to purchase/sell: |
|
|
0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
|
|
|
|
|
|
TOTAL: |
|
|
7,013,563 |
1.30% |
7,784,250 |
1.44% |
|
(b) |
Rights to subscribe for new securities (including directors and other executive |
|
|||||
|
|
options) |
|
|
|
|
|
|
|
Class of relevant security in relation to |
|
|
|
|
|||
|
which subscription right exists |
|
|
|
|
|||
|
Details, including nature of the rights |
|
|
|
|
|||
|
concerned and relevant percentages: |
|
|
|
|
|||
|
3. |
DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER |
||||||
|
(a) |
Purchases and sales |
|
|
|
|
|
|
|
Class of relevant |
Purchase/sale |
Number of |
Price per unit |
||||
|
security |
|
securities |
|
||||
|
1p ordinary |
Purchase |
70,903 |
0.6450 GBP |
||||
|
1p ordinary |
Purchase |
43,797 |
0.6445 GBP |
||||
|
1p ordinary |
Purchase |
9,371 |
0.6451 GBP |
||||
|
1p ordinary |
Purchase |
7,900 |
0.6443 GBP |
||||
|
1p ordinary |
Purchase |
4,271 |
0.6440 GBP |
||||
|
1p ordinary |
Purchase |
1,590 |
0.6449 GBP |
||||
|
1p ordinary |
Sale |
66,725 |
0.6439 GBP |
||||
|
1p ordinary |
Sale |
27,975 |
0.6450 GBP |
||||
|
1p ordinary |
Sale |
5,959 |
0.6449 GBP |
||||
|
1p ordinary |
Sale |
5,150 |
0.6440 GBP |
||||
|
|
|
|
|
|
|
|
|
|
(b) |
Cash-settled derivative transactions |
|
|||||
|
Class of |
Product |
Nature of dealing |
Number of |
Price per |
|||
|
relevant |
description |
|
reference |
unit |
|||
|
security |
|
|
securities |
|
|||
|
1p ordinary |
SWAP |
Decreasing Short |
66,725 |
0.6439 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Short |
5,959 |
0.6449 GBP |
|||
|
1p ordinary |
SWAP |
Decreasing Short |
23,635 |
0.6450 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Short |
17,080 |
0.6446 GBP |
|||
|
1p ordinary |
SWAP |
Increasing Short |
53,529 |
0.6450 GBP |
|||
|
1p ordinary |
CFD |
Increasing Short |
4,626 |
0.6446 GBP |
|||
|
|
|
|
|
|
|
|
|
|
(c) |
Stock-settled derivative transactions (including options) |
|
|||||
|
(i) |
Writing, selling, purchasing or varying |
|
|||||
|
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
of |
description |
purchasing, |
of |
price |
|
date |
money |
|
relevant |
|
selling, |
securities |
per unit |
|
|
paid/ |
|
security |
|
varying etc |
to which |
|
|
|
received |
|
|
|
|
option |
|
|
|
per unit |
|
|
|
|
relates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercising |
|
|
|
|
|
|
|
Class of relevant |
Product description |
Exercising/ exercised against |
Number of |
Exercise price per |
|||
|
security |
|
|
securities |
unit |
|||
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including subscribing for new securities) |
|
|||||
|
Class of relevant |
Nature of Dealings |
Details |
Price per unit (if |
||||
|
security |
|
|
applicable) |
||||
|
|
|
|
|
||||
|
4. |
OTHER INFORMATION |
||||||
|
(a) |
Indemnity and other dealings arrangements |
|
|||||
|
Details of any indemnity or option arrangement, or any agreement or understanding, |
|
|
|||||
|
formal or informal, relating to relevant securities which may be an inducement to deal |
|
|
|||||
|
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party |
|
||||||
|
to the offer or any person acting in concert with a party to the offer: |
|
|
|
||||
|
NONE |
|||||||
|
(b) |
Agreements, arrangements or understandings relating to options or derivatives |
|
|||||
|
Details of any agreement, arrangement or understanding, formal or informal, between |
|
|
|||||
|
the person making the disclosure and any other person relating to: |
|
|
|||||
|
(i) the voting rights of any relevant securities under any option; or |
|
|
|
||||
|
(ii) the voting rights of future acquisition or disposal of any relevant securities to which |
|
|
|||||
|
any derivative is referenced: |
|
|
|
|
|
|
|
|
NONE |
|||||||
|
(c) |
Attachments |
|
|
|
|
|
|
|
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
|
Date of disclosure: |
29 Apr 2025 |
||||||
|
Contact name: |
Large Holdings Regulatory Operations |
||||||
|
Telephone number: |
020 3134 7213 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|